Archives

We are happy to share the latest ERN ReCONNET newsletter (December 2025 edition) with our community! This issue looks back at a very active year for the network and brings together updates, [...]

The Undifferentiated Connective Tissue Disease (UCTD) Disease Group is pleased to welcome Chiara Tani, who, alongside Cristina Pamfil and ePAG Ramona Luciu, joins the coordination of the [...]

The year 2025 has been a period of significant productivity for the Systemic Sclerosis (SSc) Disease Group, marked by the completion of key projects and the launch of initiatives vital to [...]

The year 2025 has been a period of significant momentum and consolidation for the Sjögren’s Disease (SjD) Group, during which projects launched progressed significantly thanks to dynamic [...]

The year 2025 has been a period of significant progress for the Systemic Lupus Erythematosus (SLE) Disease Group, marked by new leadership under ad interim Disease Coordinators Marta Mosca and [...]

The Relapsing Polychondritis (RP) Disease Group achieved significant progress in 2025, focusing on standardizing diagnosis and improving Patient-Reported Outcomes (PROMs). The RP Disease group [...]

The year 2025 has been a period of significant progress for the Mixed Connective Tissue Disease (MCTD) Disease Group, marked by the completion of major educational and research milestones. A [...]

Throughout 2025, the ERN ReCONNET Idiopathic Inflammatory Myopathies (IIMs) Disease Group has achieved significant milestones in education, clinical research, and data standardization. A [...]

The main successes achieved include the launch of the initiative “ERN ReCONNET points to consider for the use of imaging in IgG4-RD“. This project aims to create a position statement [...]

Throughout 2025, the ERN ReCONNET Ehlers-Danlos Syndromes (EDS) Disease Group has significantly advanced its efforts to refine the diagnosis and management of generalized joint hypermobility [...]